Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model

GLIA

Volumn 55, Issue 14, 2007, Pages 1405-1415

  Briggs, Dustin T ^a   Martin, Carol B ^a,b   Ingersoll, Sarah A ^a,b   Barnum, Scott R ^c   Martin, Brian K ^a,b,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Complement; Neuroimmunology; Rodent; Transgenic mice

Indexed keywords

COMPLEMENT COMPONENT C1Q; CUPRIZONE; PROTEIN CRRY; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN; CHELATING AGENTS; COMPLEMENT SYSTEM PROTEINS; CORPUS CALLOSUM; CUPRIZONE; CYTOPROTECTION; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NERVE REGENERATION; OLIGODENDROGLIA; RECEPTORS, COMPLEMENT; TIME FACTORS;

EID: 34648825048     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20551     Document Type: Article

References (58)

1. Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ. 2003. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta 1639:169-176.
2. Allamargot C, Gardinier MV. 2007. Alternative isoforms of myelin/oligodendrocyte glycoprotein with variable cytoplasmic domains are expressed in human brain. J Neurochem 101:298-312.
3. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC. 2002. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574-8585.
4. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. 2001. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-11122.
5. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. 2003. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 23:9824-9832.
6. Barnum SR, Szalai AJ. 2006. Complement and demyelinating disease: No MAC needed? Brain Res Brain Res Rev 52:58-68.
7. Boyden KM. 2000. The pathophysiology of demyelination and the ionic basis of nerve conduction in multiple sclerosis: An overview. J Neurosci Nurs 32:49-53, 60.
8. Cole DS, Hughes TR, Gasque P, Morgan BP. 2006. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol Immunol 43:1953-1964.
9. Davoust N, Nataf S, Holers VM, Barnum SR. 1999a. Expression of the murine complement regulatory protein crry by glial cells and neurons. Glia 27:162-170.
10. Davoust N, Nataf S, Reiman R, Holers MV, Campbell IL, Barnum SR. 1999b. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J Immunol 163:6551-6556.
11. Elward K, Gasque P. 2003. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: Emphasis on the critical role of the complement system. Mol Immunol 40:85-94.
12. Foley S, Li B, Dehoff M, Molina H, Holers VM. 1993. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur J Immunol 23:1381-1384.
13. Hauwel M, Furon E, Canova C, Griffiths M, Neal J, Gasque P. 2005. Innate (inherent) control of brain infection, brain inflammation and brain repair: The role of microglia, astrocytes, "protective" glial stem cells and stromal ependymal cells. Brain Res Brain Res Rev 48:220-233.
14. He C, Alexander JJ, Lim A, Quigg RJ. 1997. Production of the rat complement regulator, Crry, as an active soluble protein in Pichia pastoris. Arch Biochem Biophys 341:347-352.
15. Helmy KY, Katschke KJ, Jr., Gorgani NN, Kljavin NM, Elliott JM, Diehl L, Scales SJ, Ghilardi N, van Lookeren Campagne M. 2006. CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124:915-927.
16. Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK. 1998. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38-49.
17. Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz, Carroll MC, Brenner M, Weisslcder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D. 2002. Arthritis critically dependent on innate immune system players. Immunity 16:157-168.
18. Johns TG, Bernard CC. 1997. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol Immunol 34:33-38.
19. Jurevics H, Largent C, Hostettler J, Sammond DW, Matsushima GK, Kleindienst A, Toews AD, Morell P. 2002. Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 82:126-136.
20. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81:302-313.
21. Komoly S. 2005. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [correction]. Ideggyogy Sz 58:40-43.
22. Kraus DM, Elliott GS, Chute H, Horan T, Pfenninger KH, Sanford SD, Foster S, Scully S, Welcher AA, Holers VM. 2006. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 176:4419-4430.
23. Lin W, Kemper A, Dupree JL, Harding HP, Ron D, Popko B. 2006. Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. Brain 129 (Part 5):1306-1318.
24. Lu QR, Yuk D, Alberta JA, Zhu Z, Pawlitzky I, Chan J, McMahon AP, Stiles CD, Rowitch DH. 2000. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 25:317-329.
25. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
26. Mana P, Linares D, Fordham S, Staykova M, Willenborg D. 2006. Deleterious role of IFNγ in a toxic model of central nervous system demyelination. Am J Pathol 168:1464-1473.
27. Mao D, Wu X, Deppong C, Friend LD, Dolecki G, Nelson DM, Molina H. 2003. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19:813-822.
28. Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK. 2000a. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61:251-262.
29. Mason JL, Xuan S, Dragatsis I, Efstratiadis A, Goldman JE. 2003. Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination. J Neurosci 23:7710-7718.
30. Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK. 2000b. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination. J Neurosci 20:5703-5708.
31. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
32. McMahon EJ, Cook DN, Suzuki K, Matsushima GK. 2001. Absence of macrophage-inflammatory protein-1α delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 167:2964-2971.
33. McMahon EJ, Suzuki K, Matsushima GK. 2002. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J Neuroimmunol 130:32-45.
34. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. 1998. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313-2320.
35. Miwa T, Nonaka M, Okada N, Wakana S, Shiroishi T, Okada H. 1998. Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): Preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics 48:363-371.
36. Molina H. 2002. The murine complement regulator Crry: New insights into the immunobiology of complement regulation. Cell Mol Life Sci 59:220-229.
37. Morell P, Barrett CV, Mason JL, Toews AD, Hostettler JD, Knapp GW, Matsushima GK. 1998. Gene expression in brain during cuprizone-induced demyelination and remyelination. Mol Cell Neurosci 12:220-227.
38. Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM. 2005. Complement: Central to innate immunity and bridging to adaptive responses. Immunol Lett 97:171-179.
39. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC. 2005. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 19:171-182.
40. Niculescu T, Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS, Shin ML, Rus H. 2004. Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. J Immunol 172:5702-5706.
41. Niculescu T, Weerth S, Soane L, Niculescu F, Rus V, Raine CS, Shin ML, Rus H. 2003. Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 1010:530-533.
42. Rancan M, Morganti-Kossmann MC, Barnum SR, Saft S, Schmidt OI, Ertel W, Stahel PF. 2003. Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice. J Cereb Blood Flow Metab 23:1070-1074.
43. Read RW, Vogt SD, Barnum SR, Szalai AJ. 2006. Experimental autoimmune uveitis in the C57BL/6 mouse. Exp Eye Res 83:229-230; author's reply 231.
44. Roos A, Xu W, Castellano G, Nauta AJ, Garred P, Daha MR, van Kooten C. 2004. Mini-review: A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34:921-929.
45. Rotshenker S. 2003. Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. J Mol Neurosci 21:65-72.
46. Selvaraju R, Bernasconi L, Losberger C, Graber P, Kadi L, Avellana-Adalid V, Picard-Riera N, Van Evercooren AB, Cirillo R, Kosco-Vilbois M, et al. 2004. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci 25:707-721.
47. Sidman RL, Abervine JB, Pierce ET. 1971. Section 241. Atlas of the mouse brain and spinal cord. Cambridge, MA: Harvard University Press.
48. Smith ME. 1999. Phagocytosis of myelin in demyelinative disease: A review. Neurochem Res 24:261-268.
49. Soane L, Rus H, Niculescu F, Shin ML. 1999. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. J Immunol 163:6132-6138.
50. Sospedra M, Martin R. 2004. Immunology of multiple sclerosis. Annu Rev Immunol 27:27.
51. Spiller OB, Hanna SM, Morgan BP. 1999. Tissue distribution of the rat analogue of decay-accelerating factor. Immunology 97:374-384.
52. Taggart HM. 1998. Multiple sclerosis update. Orthop Nurs 17:23-27; quiz 28-29.
53. Tsokos GC, Tedesco F. 2006. Complement in autoimmunity and tissue injury. Autoimmunity 39:355-356.
54. van Beek J, van Meurs M, t Hart BA, Brok HP, Neal JW, Chatagner A, Harris CL, Omidvar N, Morgan BP, Laman JD, et al. 2005. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J Immunol 174:2353-2365.
55. Webster SD, Yang AJ, Margol L, Garzon-Rodriguez W, Glabe CG, Tenner AJ. 2000. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp Neurol 161:127-138.
56. Woodruff RH, Fruttiger M, Richardson WD, Franklin RJ. 2004. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination. Mol Cell Neurosci 25:252-262.
57. Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E. 2002. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci USA 99:10837-10842.
58. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287:498-501.